| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 11/30/2005 | CN1229121C Ointment for moistening burn and scald and its making method |
| 11/30/2005 | CN1229120C Carthamus flower medicated liquor |
| 11/30/2005 | CN1229119C Chinese medicine for treating leukoderma |
| 11/30/2005 | CN1229117C Hircus treating medicament |
| 11/30/2005 | CN1229113C A Pharmaceutical composition for the treatment of autoimmune diseases |
| 11/29/2005 | US6969729 An indole or benz(g)indole-2,3-dione-3-oxime compounds; therapeutic treatment of respiratory disorders, urogenital disorders, cardiovascular disorders, brain and psychological disorders, gastrointestinal disorders |
| 11/29/2005 | US6969727 Obesity; osteoporosis |
| 11/29/2005 | US6969723 preferably antagonists used in the therapeutic and/or preventive treatment of disfunctions of the heart, kidney, respiratory system, central nervous system |
| 11/29/2005 | US6969718 17-β hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 11/29/2005 | US6969717 Azaindole kinase inhibitors |
| 11/29/2005 | US6969714 Imidazolo-5-YL-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation |
| 11/29/2005 | CA2164704C Use of cobalamins for topical treatment of dermatological illnesses |
| 11/28/2005 | CA2508093A1 Preparation for external use on skin |
| 11/26/2005 | CA2503105A1 Use of lif in cosmetics and dermatology |
| 11/26/2005 | CA2503095A1 Use of lif in cell and tissue engineering |
| 11/24/2005 | WO2005111007A1 Thiazole compound and use thereof |
| 11/24/2005 | WO2005110447A1 Oral administration preparation for skin brightness improvement |
| 11/24/2005 | US20050261750 Method and apparatus for acne treatment |
| 11/24/2005 | US20050261502 2-Amino-4-(1,3-benzodioxol-5-yl)-6-benzyloxy-3,5-pyridinedicarbonitrile, acting as adenosine-receptor-selective ligands, for the prophylaxis and/or treatment of cardiovascular disorders |
| 11/24/2005 | US20050261343 Anthranilamides and their use as pharmaceutical agents |
| 11/24/2005 | US20050261318 Protein kinase inhibitors |
| 11/24/2005 | US20050261317 Inhibitors of human phosphatidylinositol 3-kinase delta |
| 11/24/2005 | US20050261313 For angiogenesis mediated diseases; cancer; acylation, cyclization and Heck-type reduction |
| 11/24/2005 | US20050261305 Cyclic protein tyrosine kinase inhibitors |
| 11/24/2005 | US20050261303 e.g. (2R,5S)-4-(3-chloro-4-cyanophenyl)-N-(2-cyclopropylpyrimidin-5-yl)-2,5-dimethylpiperazine-1-carboxamide; antiandrogenic agent |
| 11/24/2005 | US20050261293 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 11/24/2005 | US20050261291 1-Cyclopropylmethyl-4-[2-(3,3,5,5-tetramethylcyclohexyl)phenyl]piperazine or a salt or hydrate; exhibit excellent cell adhesion inhibitory action or cell infiltration inhibitory action; for treating inflammatory diseases and autoimmune diseases such as inflammatory bowel diseases and rheumatoid arthritis |
| 11/24/2005 | US20050261281 Pharmaceutical compounds |
| 11/24/2005 | US20050261271 Dipeptidyl peptidase inhibitors |
| 11/24/2005 | US20050261269 New derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 11/24/2005 | US20050261252 LPA receptor agonists and antagonists and methods of use |
| 11/24/2005 | US20050261231 Improving tissue survival; methods for enhancing organ transplant, musculocutaneous flap or skin graft survival by administering a nucleic acid sequence encoding hepatocyte growth factor; neovascularization; surgery; tissue-targeted therapy |
| 11/24/2005 | US20050261209 Method of treating or preventing immune mediated disorders and pharmaceutical formulation for use therein |
| 11/24/2005 | US20050260747 Embryonic stem cells and neural progenitor cells derived therefrom |
| 11/24/2005 | US20050260601 Recombinant mutants of rhabdovirus and methods of use thereof |
| 11/24/2005 | US20050260565 contacting in vitro a sample comprising chemokine 88C receptor with a putative ligand, detecting binding of the 88C receptor and the putative ligand; increase in 88C signal transduction activity indicates the ligand is an activator, a decreasein transduction activity indicates the ligand is an inhibitor |
| 11/24/2005 | US20050260289 extracts from Lightyellow Sophora Root, Turmeric, Magnolia Bark, Moutan Bark extract, Isatis Leaf, Borneo Camphor Tree, Amur Cork Tree, Angelicae Dahuricae Root, Lemon, Smartweed extract, Licorice, Cnidii Rhizoma, Japanese Angelica Root extract, salicylic acid, resorcinol, alcohol, and water; eczema |
| 11/24/2005 | US20050260192 Leukocyte function associated antigens comprising integrin I-domain for use in identifying modulators for prevention and treatment of inflammatory disorders; immunosuppressive agents |
| 11/24/2005 | US20050260174 Systems and methods for treating patients with processed lipoaspirate cells |
| 11/24/2005 | DE202005014101U1 Pedicure- and wound care agents, useful in foot care, wound therapy and for prophylaxis of infection, comprises creams, cream foam, ointments, balm and interactive wound care oregano oil and/or oregano products |
| 11/24/2005 | DE102004028302B4 Stimulierung der Synthese und der Aktivität einer Isoform der Lysyloxidase-ähnlichen LOXL zum Stimulieren der Bildung von elastischen Fasern Stimulation of the synthesis and the activity of one isoform of the lysyl oxidase-like LOXL for stimulating the formation of elastic fibers |
| 11/24/2005 | DE102004028300B4 Stimulierung der Aktivität eines Isoform des Lysyloxidase zum Bekämpfen von einigen Pathologien, die durch eine unvollständige, fehlende oder desorganisierte Elastogenese verursacht sind Stimulation of the activity of an isoform of the lysyl oxidase for controlling some pathologies which are caused by an incomplete, missing or disorganized elastogenesis |
| 11/24/2005 | DE102004019753A1 Antiinflammatory finishing of hygiene articles, e.g. diapers or tampons, to prevent inflammation on contact with skin, using phytosterols, especially from avocado oil non-saponifiable components |
| 11/24/2005 | CA2566837A1 Anti acne skincare composition and skincare article |
| 11/24/2005 | CA2566625A1 Thiazole compound and use thereof |
| 11/24/2005 | CA2507712A1 Pharmaceutical compounds |
| 11/23/2005 | EP1598079A1 Remedies for allergic contact dermatitis |
| 11/23/2005 | EP1598077A1 Use of the neurotoxic component of botulinum toxins for the treatment of a spastic muscle |
| 11/23/2005 | EP1598072A1 Medical drug containing fine particle of noble metal |
| 11/23/2005 | EP1598071A1 Superoxide anion decomposing agent |
| 11/23/2005 | EP1598067A1 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors |
| 11/23/2005 | EP1598064A1 Combination of alkane diol and hydroxy acid for the treatment of acne |
| 11/23/2005 | EP1598057A1 Combination of acid protease enzymes and acidic buffers and uses thereof |
| 11/23/2005 | EP1597366A1 Modulation of insulin like growth factor i receptor expression |
| 11/23/2005 | EP1597283A2 Human antibodies specific for interleukin 15 (il-15) |
| 11/23/2005 | EP1597258A2 Novel purine derivatives, preparation method thereof, application of same as medicaments, pharmaceutical compositions and novel use |
| 11/23/2005 | EP1597233A1 Benzyl urea and thiourea derivatives useful as androgen antagonists |
| 11/23/2005 | EP1596879A1 Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis |
| 11/23/2005 | EP1596816A2 Zubereitungen eines extrakt von eperua falcata und/oder dessen inhaltstoffe enthaltend |
| 11/23/2005 | EP1596812A2 Bioadhesive liquid composition which is substantially free of water |
| 11/23/2005 | EP1455849B1 A wound care device |
| 11/23/2005 | EP1446015A4 Remodeling of tissues and organs |
| 11/23/2005 | EP1377550B9 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors |
| 11/23/2005 | EP1335898B1 Carbamic acid compounds comprising an amide linkage as hdac inhibitors |
| 11/23/2005 | EP1280777B1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues |
| 11/23/2005 | EP1250124B1 Slimming cosmetic composition comprising as active agent a plant extract containing a plant natriuretic peptide (pnp) |
| 11/23/2005 | EP1217983B1 Skincare composition against free radicals |
| 11/23/2005 | EP1165066B1 Use of lipoxin compounds for inhibiting of tnf-alpha initiated neutrophil response |
| 11/23/2005 | EP1163528B1 Prediction of diabetes impaired wound healing |
| 11/23/2005 | EP1104294B8 Compositions and methods of treating abnormal cell proliferation |
| 11/23/2005 | EP0770129B1 Zinc finger protein derivatives and methods therefor |
| 11/23/2005 | CN1701116A Probiotic bacterium: lactobacillus fermentum |
| 11/23/2005 | CN1701061A New compounds for the inhibition of rotamases and use thereof |
| 11/23/2005 | CN1700926A Composition containing beta-glucan and constipation-relieving drug, immunopotentiator and skin moistening agent using the composition |
| 11/23/2005 | CN1700916A Use of HIV-protease inhibitors to block cell migration and/or invasion, tissue inflitration and oedema formation |
| 11/23/2005 | CN1699347A Substituted pyrazolyl benzenesulfonamides for the treatment of inflamation |
| 11/23/2005 | CN1228450C Antigenic preparations |
| 11/23/2005 | CN1228083C Skin wound healing promoters |
| 11/23/2005 | CN1228058C Production method of medical healthcare beautifying product |
| 11/23/2005 | CN1228056C Powder for trauma |
| 11/23/2005 | CN1228055C Multi-function medicine for beautifying and treating scald by boiled water or fire and cold injury |
| 11/23/2005 | CN1228054C Artificial skin powder prepn containing sodium hyaluronate and its prepn |
| 11/23/2005 | CN1228042C Asiaticoside liposome and its use |
| 11/23/2005 | CN1228039C Composition containing N-vinyl iminazole polymer or copolymer and oxidation sensitive hydrophilic active ingredients for cosmetics and/or dermatology |
| 11/22/2005 | US6967245 Ucp5 |
| 11/22/2005 | US6967210 Multiple sclerosis, brain disorders, analgesics |
| 11/22/2005 | US6967197 Also used in production of tumor necrosis factor alpha |
| 11/22/2005 | US6967023 solidifying agent consists of a long chain fatty alcohol having at least 15 carbon atoms in its backbone and a fatty acid having at least 18 carbons in its backbone; carrier is semi-solid at rest and liquefies upon application of shear forces |
| 11/17/2005 | WO2005108400A1 Pyridoquinazoline derivatives having heterobicyclic substituents |
| 11/17/2005 | WO2005108399A1 Imidazopyridine compound |
| 11/17/2005 | WO2005107731A1 Remedies containing vitamin k2 as the active ingredient |
| 11/17/2005 | WO2005107694A1 Topical cypress essential oil composition for stretch marks |
| 11/17/2005 | US20050256333 4-(3-(2,6-Dimethoxybenzyloxy)phenyl)-4-oxobutyric acid or derivatives for treatment of insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis or arteriosclerosis |
| 11/17/2005 | US20050256315 1h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
| 11/17/2005 | US20050256311 Pyrimidine compounds |
| 11/17/2005 | US20050256201 Phenethanolamine derivatives |
| 11/17/2005 | US20050256171 Pyrrolidine derivatives as tryptase inhibitors |
| 11/17/2005 | US20050256166 Nitrogen-containing compounds |
| 11/17/2005 | US20050256160 Beta-alanine derivatives and the use thereof |
| 11/17/2005 | US20050256142 New purine derivatives |